GSK Unveils Two-Year Plan For Consumer Split

06 Feb 2020

GSK preparing to seize “a major opportunity to create a new leader in consumer health” with two-year program which will see the company split in two and create the world's biggest standalone OTC player.

GlaxoSmithKline PLC has set out concrete plans for creating the world’s largest standalone consumer healthcare company by 2022.

Unveiling a two-year separation program, the UK-based pharma giant's CEO Emma Walmsley said GSK would seize “a major opportunity to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Poland’s Formeds Acquired By Private Equity

05 Jun 2025

• By Tom Gallen

Enterprise Investors takes 77% stake in Polish clean-label dietary supplements manufacturer Formeds.

BioGaia Takes Probiotics To Netherlands For First Time

02 Jun 2025

• By Tom Gallen

Adopting an online approach, BioGaia is set to enter the Dutch market for probiotic dietary supplements. The firm announced the move as it reported lower sales in Q1.

Urgo Makes Moves In Poland And Belgium

29 May 2025

• By Tom Gallen

French consumer health player Urgo has added to its dietary supplements offering with separate deals in Poland and Belgium.

Dermapharm Seeks To Put Stop To Spanish Slide

23 May 2025

• By Tom Gallen

Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.

IQVIA Consumer Health: Digestive Category Driving Global OTC Market Growth

27 May 2025

• By David Ridley

An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.